Reference
Razavi S, et al. Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration. BMC Ophthalmology 21: 90, No. 1, 17 Feb 2021. Available from: URL: http://doi.org/10.1186/s12886-021-01841-6
Rights and permissions
About this article
Cite this article
Aflibercept/ranibizumab. Reactions Weekly 1863, 20 (2021). https://doi.org/10.1007/s40278-021-98624-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-98624-0